The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Relationship of the microRNA-223/FBXW7/MCL1 pathway and the sensitivity of HER2-positive gastric cancer cells to trastuzumab.
Eto Kojiro
No relevant relationships to disclose
Masaaki Iwatsuki
No relevant relationships to disclose
Takatsugu Ishimoto
No relevant relationships to disclose
Hideo Baba
No relevant relationships to disclose